Analysts: PharMerica Corp (PMC.N)

PMC.N on New York Stock Exchange

14.79USD
1 Aug 2013
Price Change (% chg)

$0.15 (+1.02%)
Prev Close
$14.64
Open
$14.73
Day's High
$14.81
Day's Low
$14.60
Volume
40,975
Avg. Vol
69,219
52-wk High
$16.44
52-wk Low
$9.85

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 0.32 December 2 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 1 1 2
(3) HOLD 4 5 5 4
(4) UNDERPERFORM 1 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.71 2.57 2.57 2.43

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 6 402.11 414.00 384.40 486.91
Quarter Ending Dec-13 6 403.01 408.88 391.31 479.23
Year Ending Dec-13 7 1,660.52 1,687.10 1,621.00 1,927.82
Year Ending Dec-14 7 1,560.62 1,649.40 1,453.59 1,967.48
Earnings (per share)
Quarter Ending Sep-13 7 0.32 0.33 0.30 0.32
Quarter Ending Dec-13 7 0.36 0.40 0.33 0.32
Year Ending Dec-13 6 1.49 1.55 1.45 1.27
Year Ending Dec-14 7 1.47 1.71 1.10 1.38
LT Growth Rate (%) 1 10.00 10.00 10.00 14.70

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 436.74 439.80 3.06 0.70
Quarter Ending Dec-12 432.43 433.20 0.77 0.18
Quarter Ending Sep-12 446.35 442.00 4.35 0.98
Quarter Ending Jun-12 488.48 458.50 29.98 6.14
Quarter Ending Mar-12 493.29 498.90 5.61 1.14
Earnings (per share)
Quarter Ending Mar-13 0.34 0.46 0.12 36.46
Quarter Ending Dec-12 0.29 0.33 0.04 12.94
Quarter Ending Sep-12 0.30 0.33 0.03 11.22
Quarter Ending Jun-12 0.30 0.32 0.02 5.12
Quarter Ending Mar-12 0.27 0.30 0.03 10.58

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 402.11 402.11 402.11 402.11 486.91
Quarter Ending Dec-13 403.01 403.01 403.01 403.01 479.23
Year Ending Dec-13 1,660.52 1,660.52 1,656.16 1,656.16 1,927.82
Year Ending Dec-14 1,560.62 1,560.62 1,581.52 1,631.82 1,967.48
Earnings (per share)
Quarter Ending Sep-13 0.32 0.32 0.31 0.31 0.32
Quarter Ending Dec-13 0.36 0.36 0.36 0.36 0.32
Quarter Ending Dec-13 1.49 1.49 1.48 1.48 1.27
Quarter Ending Dec-14 1.47 1.47 1.51 1.54 1.38

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 0 0 1 0
Year Ending Dec-14 0 0 0 1
Earnings
Quarter Ending Sep-13 0 0 1 0
Quarter Ending Dec-13 0 0 1 0
Year Ending Dec-13 0 0 1 0
Year Ending Dec-14 0 0 0 1

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$15.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks